Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2006 2
2007 2
2008 1
2009 1
2010 2
2011 2
2013 2
2015 3
2016 3
2017 3
2018 8
2019 11
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiota and Cancer: From Pathogenesis to Therapy.
Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Vivarelli S, et al. Among authors: Banna GL. Cancers (Basel). 2019 Jan 3;11(1):38. doi: 10.3390/cancers11010038. Cancers (Basel). 2019. PMID: 30609850 Free PMC article. Review.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Bersanelli M, Giannarelli D, Castrignanò P, Fornarini G, Panni S, Mazzoni F, Tiseo M, Rossetti S, Gambale E, Rossi E, Papa A, Cortellini A, Lolli C, Ratta R, Michiara M, Milella M, De Luca E, Sorarù M, Mucciarini C, Atzori F, Banna GL, La Torre L, Vitale MG, Massari F, Rebuzzi SE, Facchini G, Schinzari G, Tomao S, Bui S, Vaccaro V, Procopio G, De Giorgi U, Santoni M, Ficorella C, Sabbatini R, Maestri A, Natoli C, De Tursi M, Di Maio M, Rapacchi E, Pireddu A, Sava T, Lipari H, Comito F, Verzoni E, Leonardi F, Buti S. Bersanelli M, et al. Among authors: Banna GL. Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080. Immunotherapy. 2018. PMID: 30326787 Clinical Trial.
How to develop novel treatments for EGFR-mutant lung cancer.
Banna GL, Tiseo M. Banna GL, et al. Future Oncol. 2015;11(17):2375-8. doi: 10.2217/FON.15.172. Epub 2015 Aug 13. Future Oncol. 2015. PMID: 26270133 No abstract available.
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Addeo A, Banna GL. Addeo A, et al. Among authors: Banna GL. Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S283-S286. doi: 10.21037/tlcr.2018.07.10. Transl Lung Cancer Res. 2018. PMID: 30393623 Free PMC article. No abstract available.
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Facchinetti F, Mazzaschi G, Barbieri F, Passiglia F, Mazzoni F, Berardi R, Proto C, Cecere FL, Pilotto S, Scotti V, Rossi S, Del Conte A, Vita E, Bennati C, Ardizzoni A, Cerea G, Migliorino MR, Sala E, Camerini A, Bearz A, De Carlo E, Zanelli F, Guaitoli G, Garassino MC, Ciccone LP, Sartori G, Toschi L, Dall'Olio FG, Landi L, Pizzutilo EG, Bartoli G, Baldessari C, Novello S, Bria E, Cortinovis DL, Rossi G, Rossi A, Banna GL, Camisa R, Di Maio M, Tiseo M. Facchinetti F, et al. Among authors: Banna GL. Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25. Eur J Cancer. 2020. PMID: 32220780
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Addeo A, Banna GL. Addeo A, et al. Among authors: Banna GL. Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S287-S289. doi: 10.21037/tlcr.2018.07.09. Transl Lung Cancer Res. 2018. PMID: 30393624 Free PMC article. No abstract available.
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.
Banna GL, Passiglia F, Colonese F, Canova S, Menis J, Addeo A, Russo A, Cortinovis DL. Banna GL, et al. Crit Rev Oncol Hematol. 2018 Sep;129:27-39. doi: 10.1016/j.critrevonc.2018.06.016. Epub 2018 Jun 23. Crit Rev Oncol Hematol. 2018. PMID: 30097235 Review.
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.
De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U. De Padova S, et al. Among authors: Banna GL. Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31191451 Free PMC article. Review.
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
Pilotto S, Rossi A, Vavalà T, Follador A, Tiseo M, Galetta D, Morabito A, Di Maio M, Martelli O, Caffo O, Piovano PL, Cortinovis D, Zilembo N, Casartelli C, Banna GL, Ardizzoia A, Barzelloni ML, Bearz A, Genestreti G, Mucciarini C, Filipazzi V, Menis J, Rizzo E, Barbieri F, Rijavec E, Cecere F, Spitaleri G, Bria E, Novello S. Pilotto S, et al. Among authors: Banna GL. Clin Lung Cancer. 2018 Jan;19(1):93-104. doi: 10.1016/j.cllc.2017.05.016. Epub 2017 Jun 1. Clin Lung Cancer. 2018. PMID: 28645631 Clinical Trial.
Identifying successful biomarkers for patients with non-small-cell lung cancer.
Friedlaender A, Bauml J, Banna GL, Addeo A. Friedlaender A, et al. Among authors: Banna GL. Lung Cancer Manag. 2019 Nov 14;8(3):LMT17. doi: 10.2217/lmt-2019-0009. Lung Cancer Manag. 2019. PMID: 31807145 Free PMC article. No abstract available.
43 results
Jump to page
Feedback